Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharm-country save search
Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
Published: 2021-12-15 (Crawled : 15:00) - biospace.com/
APDN | $0.3396 0.59% 0.59% 85K
|
Commercial Services
|
| O: -4.4%
H: 5.0%
C: 4.4%
electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder
Published: 2021-12-14 (Crawled : 15:30) - biospace.com/
ECOR | $6.0 6.38% 6.0% 7.4K
|
Health Technology
|
| O: -5.91%
H: 1.38%
C: -4.44%
order
Helius Medical Technologies, Inc. Announces Issuance of U.S. Patent for Wireless PoNS®Patent Readies Company for Next Generation of PoNS Therapy
Published: 2021-12-14 (Crawled : 15:30) - biospace.com/
HSDT | $5.01 -1.96% -2.0% 4.5K
|
Health Technology
|
| O: 4.77%
H: 0.0%
C: -0.51%
pons patent therapy
Quest Diagnostics Acquires South Carolina-based Labtech Diagnostics
Published: 2021-12-14 (Crawled : 14:30) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M
|
Health Services
|
| O: -0.09%
H: 1.39%
C: 0.81%
diagnostic diagnostics
Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare ConferenceThursday, January 13, 2022 at 8:15 am Pacific Time / 11:15 am Eastern Time
Published: 2021-12-14 (Crawled : 13:30) - biospace.com/
AVXL | News | $3.8 0.0% 2.1M
|
Health Technology
|
| O: -3.52%
H: 2.04%
C: 0.39%
health thc conference j.p. morgan healthcare conference life science anavex
Targeted Therapies Plus Radiation on Cusp of Making an Impact for Patients
Published: 2021-12-14 (Crawled : 05:00) - biospace.com/
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: 2.22%
H: 0.0%
C: -4.82%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: -0.29%
H: 0.78%
C: -0.15%
therapy
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Published: 2021-12-13 (Crawled : 23:00) - biospace.com/
TRVN | $0.35 -4.37% -4.57% 170K
|
Health Technology
|
| O: 6.24%
H: 0.0%
C: 0.0%
trv045 diabetic diabetes
Teleflex Receives Reimbursement Approval for the UroLift® System in JapanWill expand patient access to breakthrough BPH treatment
Published: 2021-12-13 (Crawled : 23:00) - biospace.com/
TFX | $206.56 -0.4% 0.0% 420K
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
urolift treatment approval
Harmony Biosciences Publishes Pitolisant Efficacy Data In CNS Drugs
Published: 2021-12-13 (Crawled : 16:00) - biospace.com/
HRMY | $29.42 1.34% 1.33% 390K
|
Health Technology
|
| O: -3.85%
H: 0.0%
C: 0.0%
drug bioscience
Largest Study to Date Demonstrates Most Blood Cancer Patients Benefit From a Third Primary Dose of mRNA COVID-19 Vaccine
Published: 2021-12-13 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
covid-19 blood covid cancer vaccine
BIOHAVEN ANNOUNCES NURTEC® ODT RECEIVES FIRST GLOBAL APPROVAL OUTSIDE THE U.S. FOR PREVENTION OF MIGRAINE
Published: 2021-12-13 (Crawled : 13:00) - biospace.com/
BHVN 1 d | $38.99 -7.52% 0.0% 3.4M
|
Health Technology
|
| O: -2.49%
H: 0.0%
C: 0.0%
nurtec approval migraine
BrainStorm Cell Therapeutics Announces peer reviewed publication of NurOwn's® Phase 3 Study for ALS in Muscle and Nerve
Published: 2021-12-13 (Crawled : 13:00) - biospace.com/
BCLI A | $0.5384 4.69% 4.48% 1M
|
Health Technology
|
| O: -3.36%
H: 0.0%
C: 0.0%
nurown therapeutics phase 3 als
Sumitovant Biopharma Highlights Significant Clinical, Regulatory and Commercial Achievements Across its Portfolio of Companies in the Second Quarter of FY2021
Published: 2021-12-10 (Crawled : 19:00) - biospace.com/
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 0.4%
H: 0.0%
C: 0.0%
fy2021 biopharma commercialization
Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer
Published: 2021-12-09 (Crawled : 00:00) - biospace.com/
IMUX | $1.2 -5.51% -5.83% 360K
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
imu-935 prostate cancer trial phase 1 cancer enroll
Scientific Industries Announces BioMADE and Scientific Bioprocessing Partnership to Bring Digitally Simplified Bioprocessing to 20 U.S. Colleges
Published: 2021-12-09 (Crawled : 21:00) - biospace.com/
SCND | $1.3 0.5% 5.1K
|
Manufacturing
| Email alert
Add to watchlist
partnership
TYME Technologies, Inc. Announces Oral SM-88 Poster Accepted for Presentation at the 2022 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium
Published: 2021-12-09 (Crawled : 12:30) - biospace.com/
TYME | $0.3107 -8.21%
|
Health Technology
|
| O: 2.47%
H: 4.7%
C: -2.28%
sm-88 gastrointestinal presentation test cancer symposium
Petros Pharmaceuticals Announces Positive Over-the-Counter (OTC) Label Comprehension Study Results for Erectile Dysfunction Drug STENDRA® (avanafil)
Published: 2021-12-08 (Crawled : 15:30) - biospace.com/
PTPI | $0.6849 -1.86% -1.9% 150K
|
|
| O: 5.98%
H: 5.65%
C: 1.61%
stendra drug positive results
IsoPlexis to Present IsoLight® Single-Cell Proteomics Data at ASH 2021 Conference
Published: 2021-12-08 (Crawled : 13:30) - biospace.com/
ISO | $0.7616 1.09% 0
|
|
| O: -5.36%
H: 7.26%
C: 5.66%
isolight conference
Legend Biotech to Host Hybrid KOL Event Detailing CARTITUDE Data from the 63rd American Society of Hematology (ASH) Annual Meeting
Published: 2021-12-07 (Crawled : 14:00) - biospace.com/
LEGN | $46.14 -2.08% -2.12% 1.2M
|
Health Technology
|
| O: -0.09%
H: 9.78%
C: 8.43%
ema biotech iot
RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
RSPI | $0.0008 0.0% 600K
|
Manufacturing
|
| O: -21.57%
H: 32.5%
C: 31.67%
commercialization
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.